+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

U.S. Skin Boosters Market Size, Share & Trends Analysis Report By Type (Mesotherapy, Micro-needle), By Gender (Female, Male), By End-use (Medical Spa, Dermatology Clinics), And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 80 Pages
  • February 2024
  • Region: United States
  • Grand View Research
  • ID: 5943895
The U.S. skin boosters market is anticipated to reach USD 650.8 million by 2030 and is anticipated to expand at a CAGR of 8.8% during the forecast period. The rising demand for cosmetic procedures from the aging population and the growing medspas are some of the key factors contributing to the market growth. The FDA approvals for skin boosters in the U.S. are an essential element for the market growth.

The increasing number of the aging population in the U.S. demands for an increased number of skin treatments in the country. For instance, according to the U.S. Census Bureau, in 2020, the population aged 65 or older reached a mark of 55.8 million and constitutes 16.8% of the total population of the U.S. This surge in the aging population is anticipated to lead to the demand of cosmetic procedures such as skin boosters, thereby driving the market growth.

U.S. Skin Boosters Market Report Highlights

  • Based on type, the mesotherapy segment dominated the market with a revenue share of over 50% in 2023 and is also expected to register the fastest CAGR over the forecast period owing to the rising adoption of the procedure
  • Based on gender, the female segment held the largest market share of around 85% in 2023 and is also expected to witness the fastest CAGR over the forecast period pertaining to the growing popularity of the anti-aging non-invasive or minimally invasive cosmetic procedures
  • Financial accessibility to non-invasive cosmetic surgeries, increasing consciousness of skincare and beauty and rising geriatric population are contributing to the growing prevalence of the usage of skin boosters treatment.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Gender
1.2.3. End-use
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Gender outlook
2.2.3. End-use outlook
2.3. Competitive Insights
Chapter 3. U.S. Skin Boosters Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. U.S. Skin Boosters Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. U.S. Skin Boosters Market: Type Estimates & Trend Analysis
4.1. Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global U.S. Skin Boosters Market by Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
4.4.1. Mesotherapy
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Micro-needle
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Skin Boosters Market: Gender Estimates & Trend Analysis
5.1. Gender Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. Skin Boosters Market by Treatment Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
5.4.1. Female
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Male
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Skin Boosters Market: End-use Estimates & Trend Analysis
6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. U.S. Skin Boosters Market by End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
6.4.1. Medical Spa
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Dermatology Clinics
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company heat map analysis, 2023
7.4. Company Profiles
7.4.1. Bloomage Biotech Co. Ltd.
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Medytox Inc.
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. AbbVie Inc.
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Merz Pharma
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Galderma
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. Teoxane
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. IBSA farmaceutici Italia Srl
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. PharmaResearch Co. Ltd.
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 U.S. Skin Boosters Market, by type, 2018 - 2030 (USD Million)
Table 3 U.S. Skin Boosters Market, by gender, 2018 - 2030 (USD Million)
Table 4 U.S. Skin Boosters Market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. Skin Boosters Market: market outlook
Fig. 9 Parent market outlook
Fig. 10 Related/ancillary market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 U.S. skin boosters market driver impact
Fig. 13 U.S. skin boosters market restraint impact
Fig. 14 U.S. skin boosters market strategic initiatives analysis
Fig. 15 U.S. skin boosters market: Type movement analysis
Fig. 16 U.S. skin boosters market: Type outlook and key takeaways
Fig. 17 U.S. skin boosters market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Others estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 U.S. skin boosters market: Gender movement Analysis
Fig. 20 U.S. skin boosters market: Gender outlook and key takeaways
Fig. 21 Female market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Male market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 23 U.S. skin boosters market: End-use movement analysis
Fig. 24 U.S. skin boosters market: End-use outlook and key takeaways
Fig. 25 Medical spa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Dermatology clinics market estimates and forecasts,2018 - 2030 (USD Million)

Companies Mentioned

  • Bloomage Biotech Co. Ltd.
  • Medytox Inc.
  • AbbVie Inc.
  • Merz Pharma
  • Galderma
  • Teoxane
  • IBSA farmaceutici Italia Srl
  • PharmaResearch Co. Ltd.

Methodology

Loading
LOADING...

Table Information